Autologous fibrin matrices: A potential source of biological mediators that modulate tendon cell activities

Journal of Biomedical Materials Research - Part A

Volumn 77, Issue 2, 2006, Pages 285-293

  Anitua, Eduardo ^a   Sanchez, Mikel ^b   Nurden, Alan T ^c   Zalduendo, Mar ^a   De La Fuente, Maria ^a   Orive, Gorka ^a   Azofra, Juan ^b   Andia, Isabel ^a  

^a Biotechnology Institute I MAS D   (Spain)

^b Unidad de Cirugia Artroscopica Mikel Sanchez   (Spain)

^c HAUT LÉVÊQUE HOSPITAL   (France)

Author keywords

Angiogenesis; Fibrin matrices; Growth factors; Platelets; Tendon

Indexed keywords

BIOMEDICAL ENGINEERING; CELL PROLIFERATION; GROWTH KINETICS; PLATELETS; TENDONS;

ANGIOGENESIS; FIBRIN MATRICES; GROWTH FACTORS; VASCULAR EFFECTS;

PROTEINS;

ANGIOGENIC FACTOR; COLLAGEN TYPE 1; FIBRIN; SCATTER FACTOR; VASCULOTROPIN; BIOMATERIAL; HGF PROTEIN, HUMAN; TGFB1 PROTEIN, HUMAN; TRANSFORMING GROWTH FACTOR BETA; TRANSFORMING GROWTH FACTOR BETA1; VASCULOTROPIN A;

ACHILLES TENDON; ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CELL ACTIVITY; CELL DENSITY; CELL PROLIFERATION; CONTROLLED STUDY; NEOVASCULARIZATION (PATHOLOGY); NONHUMAN; SHEEP; TENDON GRAFT; ANIMAL; CELL CULTURE; CHEMISTRY; CULTURE TECHNIQUE; CYTOLOGY; EVALUATION; EXTRACELLULAR MATRIX; HUMAN; MATERIALS TESTING; METABOLISM; THROMBOCYTE;

ACHILLES TENDON; ANIMALS; BIOCOMPATIBLE MATERIALS; BLOOD PLATELETS; CELL CULTURE TECHNIQUES; CELL PROLIFERATION; CELLS, CULTURED; COLLAGEN TYPE I; EXTRACELLULAR MATRIX; FIBRIN; HEPATOCYTE GROWTH FACTOR; HUMANS; MATERIALS TESTING; SHEEP; TRANSFORMING GROWTH FACTOR BETA; TRANSFORMING GROWTH FACTOR BETA1; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 33749047643     PISSN: 15493296     EISSN: 15524965     Source Type: Journal    
DOI: 10.1002/jbm.a.30585     Document Type: Article

References (25)

1. Riley G. The pathogenesis of tendinopathy. A molecular perspective. Rheumatology 2004;43:131-142.
2. Kader D, Sakena A, Movin T, Magulli N. Achilles tendinopathy: Some aspects of basic science and clinical management. Br J Sports Med 2002;36:239-249.
3. Hsu C, Chang J. Clinical implications of growth factors in flexor tendon wound healing. J Hand Surg [Am] 2004;29:551-563.
4. Mafulli N, Moller HD, Evans CH. Tendon healing: Can it be optimised? Br J Sports Med 2002;36:315-316.
5. Dahlgren LA, Mohammed HO, Nixon AJ. Temporal expression of growth factors and matrix molecules in healing tendon lesions. J Orthop Res 2005;23:84-92.
6. Carter CA, Jolly DG, Worden CE Sr, Hendren DG, Kane CJM. Platelet-rich plasma gel promotes differentiation and regeneration during equine wound healing. Exp Mol Pathol 2003;74: 244-255.
7. Anitua E, Andia I, Ardanza B, Nurden P, Nurden AT. Autologous platelets as a source for healing and tissue regeneration. Thromb Haemost 2004;91:4-15.
8. Margolis DJ, Kantor J, Santana J, Strom BL, Berlin JA. Effectiveness of platelet releasate for the treatment of diabetic neuropathic foot ulcers. Diabetes Care 2001;24:483-488.
9. Yamada Y, Ueda M, Naiki T, Takahashi M, Hata KI, Nagasaka T. Autogenous injectable bone for regeneration with mesenchymal stem cells and platelet-rich plasma: Tissue engineered bone regeneration. Tissue Eng 2004;5:955-964.
10. Sanchez M, Azofra J, Aizpurua B, Andía I, Anitua E. Use of autologous plasma rich in growth factors in arthroscopic surgery. Cuad Artroscopia 2003;10:12-19.
11. Anitua E, Andia I, Sanchez M, Azofra J, Zalduendo MM, de la Fuente M, Nurden P, Nurden AT. Autologous preparations rich in growth factors promote proliferation and induce VEGF and HGF production by human tendon cells in culture. J Orthop Res 2005;23:281-286.
12. Chuen FS, Chuck CY, Ping WY, Nar WW, Kim HL, Ming CK. Immunohistochemical characterization of cells in adult human patellar tendons. J Histochem Cytochem 2004;52:1151-1157.
13. Davis PK, Ho A, Dowdy SF. Biological methods for cell-cycle synchronization of mammalian cells. Biotechniques 2001;30: 1322-1331.
14. Mazzucco L, Medici D, Serra M, Panizza R, Rivara G, Orecchia S, Libener R, Cattana E, Levis A, Betta PG, Borzini P. The use of autologous platelet gel to treat difficult-to-heal wounds: A pilot study. Transfusion 2004;44:1013-1018.
15. Molloy T, Wang Y, Murrell GAC. The roles of growth factors in tendon and ligament healing. Sports Med 2003;33:381-394.
16. Sahni A, Francis CW. Vascular endothelial growth factor binds to fibrinogen and fibrin and stimulates endothelial cell proliferation. Blood 2000;96:3772-3778.
17. Schoppet M, Chavakis T, Al-Fakhri N, Kanse SM, Preissner KT. Molecular interactions and functional interference between vitronectin and transforming growth factor beta. Lab Invest 2002; 82:37-46.
18. Ferrara N. Vascular endothelial growth factor: Basic science and clinical progress. Endocr Rev 2004;25:581-611.
19. Anitua E, Sanchez M, Nurden AT, Zalduendo MM, de la Fuente M, Azofra J, Andia I. Reciprocal actions of platelet-secreted TGF-β1 on the production of VEGF and HGF by human tendon cells. Plast Reconstr Surg. Forthcoming.
20. Xin X, Yang S, Ingle G, Zlot C, Rangell L, Kowalski J, Schwall R, Ferrara N, Gerritsen ME. Hepatocyte growth factor enhances vascular endothelial growth factor-induced angiogenesis in vitro and in vivo. Am J Pathol 2001;158:1111-1120.
21. Yoshida S, Yamaguchi Y, Itami S, Yoshikawa K, Tabata Y, Matsumoto K, Nakamura T. Neutralization of hepatocyte growth factor leads to retarded cutaneous wound healing associated with decreased neovascularization and granulation tissue formation. J Invest Dermatol 2003;120:335-343.
22. Morishita R, Aoki M, Hashiya N, Makino H, Yamasaki K, Azuma J, Sawa Y, Matsuda H, Kaneda Y, Ogihara T. Safety evaluation of clinical gene therapy using hepatocyte growth factor to treat peripheral arterial disease. Hypertension 2004;33:1379-1384.
23. Gerritsen ME. HGF and VEGF: A dynamic duo. Circ Res 2005;96:272-273.
24. Min JK, Lee Y-M, Kim JH, Kim Y-M, Kim SW, Lee S-Y, Gho YS, Oh GT, Kwon Y-G. Hepatocyte growth factor supresses vascular endothelial growth factor-induced expresión of endotelial ICAM-1 and VCAM-1 by inhibiting the nuclear factor-kB pathway. Circ Res 2005;96:300-307.
25. Dai CS, Lui YH. Hepatocyte growth factor antagonizes the profibrotic action of TGF-beta 1 in mesangial cells by stabilizing smad transcriptional corepressor TGIF. J Am Soc Nephrol 2004;15:1402-1412.